Added to YB: 2021-12-10
Pitch date: 2021-12-10
KOD [bullish]
Kodiak Sciences Inc.
-71.01%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.
Market Cap
$1.2B
Pitch Price
$82.12
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.39
P/E
-5.58
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
KODIAK SCIENCES INC KOD
A summary for this pitch has not been created yet.
Read full article (0 min)